Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer

ABSTRACT Objective Stereotactic ablative radiotherapy (SABR) is renowned for its high local control (LC) rates. Nonetheless, for tumors that are either large in volume or in close proximity to critical organs at risk, the application of SABR to the entire tumor becomes impractical. This study aims t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yun Bai, Xianshu Gao, Shangbin Qin, Shanshi Li, Mingwei Ma, Xi Cao, Feng Lyu, Jiayan Chen, Xin Qi, Siwei Liu, Yan Gao, Hongzhen Li, Xiaomei Li, Xiaoying Li, Xueying Ren, Lei Huang
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-01-01
Col·lecció:	Thoracic Cancer
Matèries:	carcinoma immunotherapy nonsmall cell lung radiosurgery
Accés en línia:	https://doi.org/10.1111/1759-7714.15514
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!